Janus Henderson European Focus I holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Janus Henderson European Focus Fund Class I HFEIX
- NAV / 1-Day Return 64.60 / +0.37 %
- Total Assets 720.6M
-
Adj. Expense Ratio
1.060%
- Expense Ratio 1.060%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Europe Stock
- Investment Style Large Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 1.27%
- Turnover 159%
USD | NAV as of Jun 13, 2026 | 1-Day Return as of Jun 13, 2026, 12:11 AM GMT+0
Morningstar’s Analysis HFEIX
Will HFEIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the HFEIX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of HFEIX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 32.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Janus Henderson Cash Liquidity Fund Llc | 6.78 | 51M | Cash and Equivalents |
ASML Holding NV | 4.80 | 36M | Technology |
TotalEnergies SE | 3.72 | 28M | Energy |
Shell PLC | 3.31 | 25M | Energy |
Banco Santander SA | 3.06 | 23M | Financial Services |
Siemens AG | 2.98 | 23M | Industrials |
Erste Group Bank AG. | 2.95 | 22M | Financial Services |
Iberdrola SA | 2.91 | 22M | Utilities |
Roche Holding AG Ordinary Shares new | 2.88 | 22M | Healthcare |
Novartis AG Registered Shares | 2.86 | 22M | Healthcare |
United States